Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity
- PMID:23225881
- DOI: 10.4049/jimmunol.1201060
Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity
Abstract
The glycoproteins hemagglutinin (HA) and neuraminidase are the major determinants of host range and tissue tropism of the influenza virus. HA is the most abundant protein in the virus particle membrane and represents the basis of most influenza vaccines. It has been reported that influenza virus HA N-glycosylation markedly depends on the host cell line used for virus production. However, little is known about how differential glycosylation affects immunogenicity of the viral proteins. This is of importance for virus propagation in chicken eggs as well as for innovative influenza vaccine production in mammalian cell lines. In this study, we investigated the impact of the differential N-glycosylation patterns of two influenza A virus PR/8/34 (H1N1) variants on immunogenicity. Madin-Darby canine kidney cell-derived and Vero cell-derived glycovariants were analyzed for immunogenicity in a TCR-HA transgenic mouse model. Next-generation pyrosequencing validated the congruence of the potential HA N-glycosylation sites as well as the presence of the HA peptide recognized by the TCR-HA transgenic T cells. We show that differential HA N-glycosylation markedly affected T cell activation and cytokine production in vitro and moderately influenced IL-2 production in vivo. Cocultivation assays indicated that the difference in immunogenicity was mediated by CD11c(+) dendritic cells. Native virus deglycosylation by endo- and exoglycosidases dramatically reduced cytokine production by splenocytes in vitro and markedly decreased HA-specific Ab production in vivo. In conclusion, this study indicates a crucial importance of HA N-glycosylation for immunogenicity. Our findings have implications for cell line-based influenza vaccine design.
Similar articles
- Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture.Rödig JV, Rapp E, Bohne J, Kampe M, Kaffka H, Bock A, Genzel Y, Reichl U.Rödig JV, et al.Biotechnol Bioeng. 2013 Jun;110(6):1691-703. doi: 10.1002/bit.24834. Epub 2013 Feb 4.Biotechnol Bioeng. 2013.PMID:23297157
- Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.Schwarzer J, Rapp E, Hennig R, Genzel Y, Jordan I, Sandig V, Reichl U.Schwarzer J, et al.Vaccine. 2009 Jul 9;27(32):4325-36. doi: 10.1016/j.vaccine.2009.04.076. Epub 2009 May 14.Vaccine. 2009.PMID:19410619
- Addition of glycosylation to influenza A virus hemagglutinin modulates antibody-mediated recognition of H1N1 2009 pandemic viruses.Job ER, Deng YM, Barfod KK, Tate MD, Caldwell N, Reddiex S, Maurer-Stroh S, Brooks AG, Reading PC.Job ER, et al.J Immunol. 2013 Mar 1;190(5):2169-77. doi: 10.4049/jimmunol.1202433. Epub 2013 Jan 30.J Immunol. 2013.PMID:23365085
- Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.Montomoli E, Khadang B, Piccirella S, Trombetta C, Mennitto E, Manini I, Stanzani V, Lapini G.Montomoli E, et al.Expert Rev Vaccines. 2012 May;11(5):587-94. doi: 10.1586/erv.12.24.Expert Rev Vaccines. 2012.PMID:22827244Review.
- Continuous cell lines as a production system for influenza vaccines.Genzel Y, Reichl U.Genzel Y, et al.Expert Rev Vaccines. 2009 Dec;8(12):1681-92. doi: 10.1586/erv.09.128.Expert Rev Vaccines. 2009.PMID:19943763Review.
Cited by
- Impact of Protein Glycosylation on the Design of Viral Vaccines.Schön K, Lepenies B, Goyette-Desjardins G.Schön K, et al.Adv Biochem Eng Biotechnol. 2021;175:319-354. doi: 10.1007/10_2020_132.Adv Biochem Eng Biotechnol. 2021.PMID:32935143Review.
- Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycans.Lin SC, Jan JT, Dionne B, Butler M, Huang MH, Wu CY, Wong CH, Wu SC.Lin SC, et al.PLoS One. 2013 Jun 14;8(6):e66719. doi: 10.1371/journal.pone.0066719. Print 2013.PLoS One. 2013.PMID:23799128Free PMC article.
- Spontaneous Glycan Reattachment Following N-Glycanase Treatment of Influenza and HIV Vaccine Antigens.Keating CL, Kuhn E, Bals J, Cocco AR, Yousif AS, Matysiak C, Sangesland M, Ronsard L, Smoot M, Moreno TB, Okonkwo V, Setliff I, Georgiev I, Balazs AB, Carr SA, Lingwood D.Keating CL, et al.J Proteome Res. 2020 Feb 7;19(2):733-743. doi: 10.1021/acs.jproteome.9b00620. Epub 2020 Jan 24.J Proteome Res. 2020.PMID:31913636Free PMC article.
- Comparison of N-linked glycosylation on hemagglutinins derived from chicken embryos and MDCK cells: a case of the production of a trivalent seasonal influenza vaccine.Li J, Liu S, Gao Y, Tian S, Yang Y, Ma N.Li J, et al.Appl Microbiol Biotechnol. 2021 May;105(9):3559-3572. doi: 10.1007/s00253-021-11247-5. Epub 2021 May 3.Appl Microbiol Biotechnol. 2021.PMID:33937925Free PMC article.
- Site-specific glycosylation of SARS-CoV-2: Big challenges in mass spectrometry analysis.Campos D, Girgis M, Sanda M.Campos D, et al.Proteomics. 2022 Aug;22(15-16):e2100322. doi: 10.1002/pmic.202100322. Epub 2022 Jun 22.Proteomics. 2022.PMID:35700310Free PMC article.Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials